Business Description
![Histogen Inc Histogen Inc logo](https://static.gurufocus.com/logos/0C0000BUNT.png?14)
Histogen Inc
NAICS : 541714
SIC : 2833
ISIN : US43358Y2028
Description
Histogen Inc is a clinical-stage therapeutics company focused on developing proprietary hypoxia-generated growth factor technology platforms and stem cell-free biologic products as potential first-in-class restorative therapeutics that ignite the body's natural process to repair and maintain healthy biological function. Under its biologics technology platform, the product candidates in development are HST-003, a treatment for joint cartilage repair, and HST-004, a treatment for spinal disc repair. It also has a pipeline of clinical and preclinical small molecule pan-caspase and caspase selective inhibitors focused on treatments for infectious and inflammatory diseases that the company intends to develop.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.01 | |||||
Equity-to-Asset | 0.94 | |||||
Debt-to-Equity | 0.83 | |||||
Debt-to-EBITDA | -0.37 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -29.3 | |||||
Beneish M-Score | -38.51 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -60.6 | |||||
3-Year EBITDA Growth Rate | -27.9 | |||||
3-Year EPS without NRI Growth Rate | -27.3 | |||||
3-Year FCF Growth Rate | -8.1 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 29.91 | |||||
9-Day RSI | 39.73 | |||||
14-Day RSI | 43.67 | |||||
6-1 Month Momentum % | -6.15 | |||||
12-1 Month Momentum % | -58.1 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.05 | |||||
Quick Ratio | 4.05 | |||||
Cash Ratio | 3.39 | |||||
Days Sales Outstanding | 1363.95 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -93.4 | |||||
Shareholder Yield % | 18.84 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -63447.37 | |||||
Net Margin % | -65142.11 | |||||
FCF Margin % | -53026.32 | |||||
ROE % | -107.12 | |||||
ROA % | -80.72 | |||||
ROIC % | -234.2 | |||||
ROC (Joel Greenblatt) % | -220.86 | |||||
ROCE % | -87.98 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 52.5 | |||||
PB Ratio | 0.16 | |||||
Price-to-Tangible-Book | 0.17 | |||||
EV-to-EBIT | 0.3 | |||||
EV-to-EBITDA | 0.3 | |||||
EV-to-Revenue | -193.47 | |||||
EV-to-Forward-Revenue | 14.27 | |||||
EV-to-FCF | 0.36 | |||||
Price-to-Net-Current-Asset-Value | 0.18 | |||||
Price-to-Net-Cash | 0.21 | |||||
Earnings Yield (Greenblatt) % | 333.33 | |||||
FCF Yield % | -1123.19 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:HSTO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Histogen Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 0.019 | ||
EPS (TTM) ($) | -2.81 | ||
Beta | 1.79 | ||
Volatility % | 108.19 | ||
14-Day RSI | 43.67 | ||
14-Day ATR ($) | 0.028442 | ||
20-Day SMA ($) | 0.263 | ||
12-1 Month Momentum % | -58.1 | ||
52-Week Range ($) | 0.0501 - 0.93 | ||
Shares Outstanding (Mil) | 4.27 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Histogen Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Histogen Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Histogen Inc Frequently Asked Questions
What is Histogen Inc(HSTO)'s stock price today?
The current price of HSTO is $0.21. The 52 week high of HSTO is $0.93 and 52 week low is $0.05.
When is next earnings date of Histogen Inc(HSTO)?
The next earnings date of Histogen Inc(HSTO) is 2024-07-25 Est..
Does Histogen Inc(HSTO) pay dividends? If so, how much?
Histogen Inc(HSTO) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |